CD30.CAR-T,

Chiraag D Kapadia1, Gerardo Rosas2, Sachin G Thakkar3

  • 1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

Cytotherapy
|December 27, 2023
PubMed
概括

化学抗原受体 (CAR) T细胞疗法可能会扩大淋巴瘤患者的先前存在的克隆性血液形成 (CH). 小CH克隆,定义为变异基频率<1%,在CAR-T治疗后显著扩张.